Unidade de Cuidados na Comunidade de Guimarães
Guimarães, 4800, Portugal
NCT Number: NCT07267858
The main objective of this study is to evaluate the effects of a Clinical Pilates-based exercise programme on chest mobility, lung function, motor performance, physical activity levels, sleep quality and Health-Related Quality of Life (HRQoL) in individuals with Gold A COPD. Based on our research question, 'What is the effect of a Clinical Pilates programme on thoracic mobility, pulmonary function, motor performance, physical activity levels, sleep quality, and HRQoL in people with Gold A COPD?', we propose the following research hypotheses:
H1: The Clinical Pilates programme contributed to improved thoracic mobility in people with Gold A COPD.
H2: The Clinical Pilates programme contributed to improved lung function in people with Gold A COPD.
H3: The Clinical Pilates programme positively influences the motor performance of people with Gold A COPD.
H4: The Clinical Pilates programme positively influences the physical activity levels of people with COPD Gold A.
H5: The Clinical Pilates programme positively influences the sleep quality of people with COPD Gold A.
H6: The Clinical Pilates programme contributes to improving the HRQoL levels of people with COPD Gold A.
This study is active but is not currently recruiting participants.
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Guimarães, 4800, Portugal
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8-week programme with face-to-face sessions twice a week, lasting approximately 60 minutes per session, using equipment such as soft balls and elastic bands.
Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Chirometric tests of the Thorax (Lanza et al., 2013).
Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Peak expiratory flow - Peak Flow (Miler et al., 2005).
Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
One-minute sit-to-stand test (Vaidya et al., 2016) and modified Borg scale (Borg, 1982).
Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
Actigraph® GT3X+ accelerometer. The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend.
The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds.
A record sheet will be provided to indicate the times when the accelerometer is put on and taken off.
The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory.
Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend.
The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds.
A record sheet will be provided to indicate the times when the accelerometer is put on and taken off.
The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory.
Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.
EQ-5D-5L (Ferreira et al., 2023).
Likert scale (1 to 5) self-assessment that considers 5 domains:
University of Trás-os-Montes and Alto Douro
Other
Effect of a Clinical Pilates Programme on Individuals With Gold A COPD on Lung Function, Motor Performance, Chest Mobility, Sleep and Physical Activity, and Health-related Quality of Life: an Interactive Approach Between Rehabilitation Nursing and Sports Sciences.
Acronym: COPD_CPilates
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07262229
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
Rolle, Switzerland
View Trial DetailsNCT06884228
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
London, United Kingdom
View Trial DetailsNCT06969573
COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease
Edmonton, Alberta, Canada
View Trial DetailsNCT06723795
COPD (Chronic Obstructive Pulmonary Disease), Cardiovascular Diseases
Tel Aviv, Israel
View Trial Details